Atea Pharmaceuticals, Inc.AVIRNASDAQ

Revenue (LTM)

Net Income (LTM)

$-158M

+6.0% YoY

Free Cash Flow

$-132M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	351	0	0	0	0
Gross Profit	184	-62↓133.9%	-70↓12.3%	-83↓18.9%	-0↑99.5%
Operating Income	138	-131↓194.4%	-164↓25.7%	-193↓17.5%	-181↑6.3%
Net Income	121	-116↓195.6%	-136↓17.3%	-168↓23.9%	-158↑6.0%
EBITDA	138	-111↓180.1%	-120↓7.9%	-132↓10.2%	-181↓37.2%
EPS Diluted	1.37	-1.39↓201.5%	-1.63↓17.3%	-2.00↓22.7%	-1.94↑3.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	764	647↓15.4%	144↓77.8%	65↓55.0%	96↑47.9%
Total Current Assets	772	661↓14.4%	590↓10.7%	462↓21.7%	311↓32.7%
Total Assets	773	667↓13.7%	595↓10.8%	465↓21.9%	315↓32.2%
Total Current Liabilities	57	18↓67.5%	32↑75.2%	19↓42.5%	40↑113.9%
Total Liabilities	63	26↓58.4%	40↑52.2%	26↓35.1%	40↑54.2%
Total Equity	710	641↓9.8%	555↓13.3%	439↓21.0%	275↓37.2%
Total Debt	0	3↑1485.8%	2↓23.1%	2↓31.6%	1↓48.7%
Net Debt	-764	-644↑15.8%	-141↑78.0%	-63↑55.4%	-95↓50.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-87	-121↓39.1%	-85↑29.4%	-135↓58.7%	-132↑2.6%
Capital Expenditure	-0	-2↓48475.0%	0	0	0
Free Cash Flow	-87	-123↓41.3%	-85↑30.5%	-135↓58.7%	-132↑2.6%
Stock-Based Comp	40	47↑17.9%	49↑5.8%	52↑4.7%	21↓60.0%
Net Change in Cash	-86	-576↓573.4%	-45↑92.2%	-79↓76.5%	31↑139.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance